MedTrace Logo

Adaptation Processes in School-Based Substance Abuse Programs

NCT01755533 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2827

Last updated 2017-04-20

No results posted yet for this study

Summary

The goals of this study are to develop a middle school substance use prevention curriculum for underserved rural youth and evaluate its efficacy compared to the existing, multicultural curriculum. In addition, we are studying how the curricula get taught by the teachers.

Hypothesis 1: When compared to students in the control condition, students in the treatment conditions will report less substance use, more conservative norms, less positive expectations about substance use outcomes, and better life and communication skills.

Hypothesis 2: When compared to students in the control condition, students in the researcher adaptation condition will report less substance use, more conservative norms, less positive expectations, and better life and communication skills.

Hypothesis 3: When compared to students in the control condition, students in the teacher adaptation condition will report less substance use, more conservative norms, less positive expectations, and better life and communication skills.

Hypothesis 4: Researcher adaptation will have a greater impact on substance use, norms, and expectations than teacher adaptation.

Conditions

  • Substance Use

Interventions

OTHER

Rural curriculum

Students in schools randomly assigned to this condition receive the rural version of the curriculum.

OTHER

Classic curriculum

Students in schools randomly assigned to this condition receive the classic version of the curriculum.

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Ohio State University

    collaborator OTHER

  • Penn State University

    lead OTHER

Principal Investigators

  • Michael L Hecht, PhD · Penn State University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
11 Years
Max Age
15 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2012-06-30
Completion
2012-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01755533 on ClinicalTrials.gov